UniProt ID | GP1BA_HUMAN | |
---|---|---|
UniProt AC | P07359 | |
Protein Name | Platelet glycoprotein Ib alpha chain | |
Gene Name | GP1BA | |
Organism | Homo sapiens (Human). | |
Sequence Length | 652 | |
Subcellular Localization |
Membrane Single-pass type I membrane protein. |
|
Protein Description | GP-Ib, a surface membrane protein of platelets, participates in the formation of platelet plugs by binding to the A1 domain of vWF, which is already bound to the subendothelium.. | |
Protein Sequence | MPLLLLLLLLPSPLHPHPICEVSKVASHLEVNCDKRNLTALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRCELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCNCEILYFRRWLQDNAENVYVWKQGVDVKAMTSNVASVQCDNSDKFPVYKYPGKGCPTLGDEGDTDLYDYYPEEDTEGDKVRATRTVVKFPTKAHTTPWGLFYSWSTASLDSQMPSSLHPTQESTKEQTTFPPRWTPNFTLHMESITFSKTPKSTTEPTPSPTTSEPVPEPAPNMTTLEPTPSPTTPEPTSEPAPSPTTPEPTSEPAPSPTTPEPTSEPAPSPTTPEPTPIPTIATSPTILVSATSLITPKSTFLTTTKPVSLLESTKKTIPELDQPPKLRGVLQGHLESSRNDPFLHPDFCCLLPLGFYVLGLFWLLFASVVLILLLSWVGHVKPQALDSGQGAALTTATQTTHLELQRGRQVTVPRAWLLFLRGSLPTFRSSLFLWVRPNGRVGPLVAGRRPSALSQGRGQDLLSTVSIRYSGHSL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
37 | N-linked_Glycosylation | EVNCDKRNLTALPPD EECCCCCCCCCCCCC | 47.70 | 16263699 | |
37 | N-linked_Glycosylation | EVNCDKRNLTALPPD EECCCCCCCCCCCCC | 47.70 | 16263699 | |
129 | Phosphorylation | DVSFNRLTSLPLGAL ECCCCCCCCCCHHHH | 25.61 | - | |
130 | Phosphorylation | VSFNRLTSLPLGALR CCCCCCCCCCHHHHH | 32.36 | - | |
163 | Phosphorylation | PPGLLTPTPKLEKLS CCCCCCCCCCHHHHH | 28.02 | 18776048 | |
175 | N-linked_Glycosylation | KLSLANNNLTELPAG HHHCCCCCCCCCCHH | 48.42 | 3497398 | |
267 | Phosphorylation | ASVQCDNSDKFPVYK EEEECCCCCCCCCCC | 29.00 | 22210691 | |
292 | Sulfation | DEGDTDLYDYYPEED CCCCCCHHHCCCCCC | 12.52 | 12087105 | |
292 | Sulfation | DEGDTDLYDYYPEED CCCCCCHHHCCCCCC | 12.52 | - | |
292 | Phosphorylation | DEGDTDLYDYYPEED CCCCCCHHHCCCCCC | 12.52 | 18088087 | |
294 | Sulfation | GDTDLYDYYPEEDTE CCCCHHHCCCCCCCC | 13.83 | 12087105 | |
294 | Sulfation | GDTDLYDYYPEEDTE CCCCHHHCCCCCCCC | 13.83 | - | |
294 | Phosphorylation | GDTDLYDYYPEEDTE CCCCHHHCCCCCCCC | 13.83 | 18088087 | |
295 | Sulfation | DTDLYDYYPEEDTEG CCCHHHCCCCCCCCC | 10.98 | - | |
295 | Sulfation | DTDLYDYYPEEDTEG CCCHHHCCCCCCCCC | 10.98 | 12087105 | |
295 | Phosphorylation | DTDLYDYYPEEDTEG CCCHHHCCCCCCCCC | 10.98 | 18088087 | |
304 | Acetylation | EEDTEGDKVRATRTV CCCCCCCEEEEEEEE | 44.47 | 20167786 | |
308 | O-linked_Glycosylation | EGDKVRATRTVVKFP CCCEEEEEEEEEECC | 19.13 | UniProtKB CARBOHYD | |
353 | Phosphorylation | QESTKEQTTFPPRWT CCCCCCCCCCCCCCC | 31.34 | 27174698 | |
354 | Phosphorylation | ESTKEQTTFPPRWTP CCCCCCCCCCCCCCC | 33.56 | 27174698 | |
360 | Phosphorylation | TTFPPRWTPNFTLHM CCCCCCCCCCEEEEE | 15.05 | 29759185 | |
364 | O-linked_Glycosylation | PRWTPNFTLHMESIT CCCCCCEEEEEEEEE | 23.53 | OGP | |
476 | Phosphorylation | TSLITPKSTFLTTTK CCCCCCCCCCCCCCC | 42.55 | 29759185 | |
477 | Phosphorylation | SLITPKSTFLTTTKP CCCCCCCCCCCCCCC | 58.46 | 29759185 | |
494 | O-linked_Glycosylation | LLESTKKTIPELDQP HHHHHCCCCCCCCCC | 12.49 | OGP | |
589 | Phosphorylation | LQRGRQVTVPRAWLL ECCCCCCCCCHHHHH | 37.70 | 24719451 | |
601 | Phosphorylation | WLLFLRGSLPTFRSS HHHHHHCCCCCCCCE | 28.71 | 28060719 | |
603 | Phosphorylation | LFLRGSLPTFRSSLF HHHHCCCCCCCCEEE | 39.78 | 18088087 | |
604 | Phosphorylation | FLRGSLPTFRSSLFL HHHCCCCCCCCEEEE | 17.57 | 28270605 | |
606 | Phosphorylation | RGSLPTFRSSLFLWV HCCCCCCCCEEEEEE | 30.24 | 18088087 | |
607 | Phosphorylation | GSLPTFRSSLFLWVR CCCCCCCCEEEEEEC | 46.59 | 24719451 | |
608 | Phosphorylation | SLPTFRSSLFLWVRP CCCCCCCEEEEEECC | 32.10 | 28270605 | |
625 | Phosphorylation | RVGPLVAGRRPSALS CCCCCCCCCCCCHHH | 39.02 | 10559231 | |
629 | Phosphorylation | LVAGRRPSALSQGRG CCCCCCCCHHHCCCC | 23401153 | ||
632 | Phosphorylation | GRRPSALSQGRGQDL CCCCCHHHCCCCCCH | 23401153 | ||
641 | Phosphorylation | GRGQDLLSTVSIRYS CCCCCHHHEEEEEEC | 28060719 | ||
642 | Phosphorylation | RGQDLLSTVSIRYSG CCCCHHHEEEEEECC | 28060719 | ||
644 | Phosphorylation | QDLLSTVSIRYSGHS CCHHHEEEEEECCCC | 29970186 | ||
647 | Phosphorylation | LSTVSIRYSGHSL-- HHEEEEEECCCCC-- | 28270605 | ||
648 | Phosphorylation | STVSIRYSGHSL--- HEEEEEECCCCC--- | 28270605 | ||
651 | Phosphorylation | SIRYSGHSL------ EEEECCCCC------ | 10559231 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of GP1BA_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of GP1BA_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
VWF_HUMAN | VWF | physical | 12183630 | |
FA12_HUMAN | F12 | physical | 10801853 | |
1433Z_HUMAN | YWHAZ | physical | 9454760 | |
1433Z_HUMAN | YWHAZ | physical | 8631758 | |
FLNA_HUMAN | FLNA | physical | 11700320 | |
LYAM3_HUMAN | SELP | physical | 10499919 | |
FLNB_HUMAN | FLNB | physical | 9651345 | |
FLNA_HUMAN | FLNA | physical | 25241761 | |
FA12_HUMAN | F12 | physical | 25241761 | |
GPIX_HUMAN | GP9 | physical | 12693941 | |
GP1BB_HUMAN | GP1BB | physical | 12693941 | |
1433Z_HUMAN | YWHAZ | physical | 22754302 | |
VWF_HUMAN | VWF | physical | 2690940 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
258660 | Non-arteritic anterior ischemic optic neuropathy (NAION) | |||||
231200 | Bernard-Soulier syndrome (BSS) | |||||
153670 | Bernard-Soulier syndrome A2, autosomal dominant (BSSA2) | |||||
177820 | Pseudo-von Willebrand disease (VWDP) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
N-linked Glycosylation | |
Reference | PubMed |
"Elucidation of N-glycosylation sites on human platelet proteins: aglycoproteomic approach."; Lewandrowski U., Moebius J., Walter U., Sickmann A.; Mol. Cell. Proteomics 5:226-233(2006). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-37, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Phosphoproteome of resting human platelets."; Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,Schuetz C., Walter U., Gambaryan S., Sickmann A.; J. Proteome Res. 7:526-534(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-292; TYR-294; TYR-295;SER-603 AND SER-606, AND MASS SPECTROMETRY. | |
Sulfation | |
Reference | PubMed |
"Crystal structure of the platelet glycoprotein Ibalpha N-terminaldomain reveals an unmasking mechanism for receptor activation."; Uff S., Clemetson J.M., Harrison T., Clemetson K.J., Emsley J.; J. Biol. Chem. 277:35657-35663(2002). Cited for: X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 17-304, AND SULFATION ATTYR-292; TYR-294 AND TYR-295. |